Atea Pharmaceuticals Inc. (NASDAQ:AVIR) went down by -3.64% from its latest closing price compared to the recent 1-year high of $94.17. The company’s stock price has collected -32.48% of loss in the last five trading sessions. Press Release reported on 11/22/21 that Atea Pharmaceuticals to Present at the 4th Annual Evercore ISI HealthCONx Conference
Is It Worth Investing in Atea Pharmaceuticals Inc. (NASDAQ :AVIR) Right Now?
Atea Pharmaceuticals Inc. (NASDAQ:AVIR) scored a price-to-earnings ratio above its average ratio, recording 28.20 x from its present earnings ratio. Opinions of the stock are interesting as 2 analysts out of 5 who provided ratings for Atea Pharmaceuticals Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 3 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $13.67, which is $6.0 above the current price. AVIR currently public float of 67.80M and currently shorts hold a 9.25% ratio of that float. Today, the average trading volume of AVIR was 4.78M shares.
AVIR’s Market Performance
AVIR stocks went down by -32.48% for the week, with a monthly drop of -39.70% and a quarterly performance of -74.89%, while its annual performance rate touched -77.13%. The volatility ratio for the week stands at 9.97% while the volatility levels for the past 30 days are set at 6.76% for Atea Pharmaceuticals Inc.. The simple moving average for the period of the last 20 days is -29.32% for AVIR stocks with a simple moving average of -78.29% for the last 200 days.
Analysts’ Opinion of AVIR
JP Morgan, on the other hand, stated in their research note that they expect to see AVIR reach a price target of $16, previously predicting the price at $61. The rating they have provided for AVIR stocks is “Neutral” according to the report published on October 20th, 2021.
Morgan Stanley gave a rating of “Equal-Weight” to AVIR, setting the target price at $55 in the report published on October 05th of the current year.
AVIR Trading at -67.07% from the 50-Day Moving Average
After a stumble in the market that brought AVIR to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -91.86% of loss for the given period.
Volatility was left at 6.76%, however, over the last 30 days, the volatility rate increased by 9.97%, as shares sank -38.10% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -72.33% lower at present.
During the last 5 trading sessions, AVIR fell by -32.48%, which changed the moving average for the period of 200-days by -91.19% in comparison to the 20-day moving average, which settled at $10.62. In addition, Atea Pharmaceuticals Inc. saw -81.64% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for AVIR
Current profitability levels for the company are sitting at:
- -22.68 for the present operating margin
The net margin for Atea Pharmaceuticals Inc. stands at -22.51. The total capital return value is set at -3.89, while invested capital returns managed to touch -3.86. Equity return is now at value 4.30, with 2.90 for asset returns.
The receivables turnover for the company is 16.73 and the total asset turnover is 0.11. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.73.